Valuation: Eckert & Ziegler SE

Market Cap 762M 866M 717M 656M 1.23B 83.16B 1.24B 8.6B 3.34B 42.4B 3.25B 3.18B 138B P/E 2026 *
14.9x
P/E 2027 * 14.1x
Enterprise Value 646M 735M 608M 556M 1.04B 70.52B 1.05B 7.29B 2.83B 35.95B 2.76B 2.7B 117B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.87x
Free-Float
67.36%
Yield 2026 *
1.73%
Yield 2027 * 1.77%
1 day-9.48%
Current month-9.48%
1 month-9.48%
3 months-17.71%
1 month 11.82
Extreme 11.824
11.85
Current year 11.82
Extreme 11.824
14.67
1 year 11.82
Extreme 11.824
14.67
3 years 11.82
Extreme 11.824
14.67
5 years 11.82
Extreme 11.824
14.67
10 years 11.82
Extreme 11.824
14.67
Manager TitleAgeSince
Chief Executive Officer 59 06/06/2023
Chief Tech/Sci/R&D Officer - 31/12/2024
Chief Operating Officer 59 31/12/2024
Director TitleAgeSince
Chairman 57 06/06/2023
Director/Board Member 66 31/12/2013
Director/Board Member 58 31/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
-9.48%0.00% - - 881M
+4.86%+9.45%+26.33%-16.55% 18.05B
-5.20%-1.65%-40.51%+23.38% 1.95B
-1.54%+1.16%-32.35%+22.85% 881M
+0.11%0.00%+52.02%-1.91% 778M
+3.38%-0.74%-61.04%-85.08% 709M
-0.69%+8.73%-29.95%-46.60% 691M
+1.77%+2.48%-36.80%-51.24% 579M
+5.30%+16.13%+52.58%+90.73% 452M
-0.95%+1.96%-6.83%+0.85% 404M
Average -0.24%+3.11%-8.51%-7.06% 2.72B
Weighted average by Cap. +2.87%+3.65%+14.04%-12.87%

Financials

2026 *2027 *
Net sales 318M 362M 300M 274M 512M 34.72B 516M 3.59B 1.39B 17.7B 1.36B 1.33B 57.45B 342M 389M 322M 294M 550M 37.32B 554M 3.86B 1.5B 19.03B 1.46B 1.43B 61.76B
Net income 51.68M 58.79M 48.68M 44.49M 83.15M 5.64B 83.83M 583M 226M 2.88B 221M 216M 9.34B 53.08M 60.39M 50M 45.7M 85.41M 5.8B 86.11M 599M 233M 2.96B 227M 222M 9.59B
Net Debt -116M -132M -109M -99.65M -186M -12.64B -188M -1.31B -507M -6.44B -494M -484M -20.92B -123M -139M -115M -105M -197M -13.38B -199M -1.38B -537M -6.82B -523M -512M -22.13B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.17EUR
Average target price
21.60EUR
Spread / Average Target
+77.49%

Annual profits - Rate of surprise